FDA Alerts Pharmaceutical Companies to Potentially Faulty Testing

January 11, 2007

U.S. officials are notifying pharmaceutical companies about more than 1,100 generic and brand-name drugs that might have been approved or are awaiting approval based on faulty testing. (HealthDay)

Posted by

Posted in Biotech, News